MarketCap
Facebook
X
TelegramQuartalsbericht 2022-Q3
hinzugefügt 15.12.2022
OncoSec Medical Incorporated ROE 2011-2026 | ONCS
ROE Jährlich OncoSec Medical Incorporated
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -558.64 | -118.63 | -304.63 | -124.7 | -170.72 | -200.54 | -95.85 | -64.97 | -31.55 | -150.88 | -53.43 | 158.94 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 158.94 | -558.64 | -142.97 |
ROE Vierteljährlich OncoSec Medical Incorporated
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 678.91 | 706.68 | -101.3 | -164.15 | -151.97 | -559.17 | -606.57 | -687.86 | -736.53 | -340.81 | -323.14 | -282.9 | -265.23 | -291.06 | -257.31 | -225.99 | -192.24 | -160.05 | -173.56 | -156.13 | -181.23 | -178.5 | -158.63 | -126.88 | -91.69 | -81.87 | -84.02 | -80.74 | -79.08 | -78.04 | -63.92 | -53.11 | -45.83 | -52.3 | -54.07 | -82.16 | -82.51 | 68.73 | 6.74 | -9.29 | -43.7 | 292.22 | 834.65 | 1047.02 | 511.2 | 466.94 | 158.94 | -114.68 |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1047.02 | -736.53 | -55.13 |
ROE anderer Aktien in der Pharmaeinzelhändler
| Name | ROE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
15.76 | - | 2.43 % | $ 254 M |  Germany |
 |
AgeX Therapeutics
AGE
|
51843.24 | - | -10.17 % | $ 12.2 K |  USA |
 |
BioNTech SE
BNTX
|
1.11 | $ 95.5 | - | $ 27.2 B | Germany |
 |
I-Mab
IMAB
|
-85.31 | - | - | $ 866 M |  China |
 |
Midatech Pharma plc
MTP
|
-330.29 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
5.18 | - | - | $ 40.3 B | USA |
 |
Biophytis SA
BPTS
|
-751.94 | - | -13.47 % | $ 169 M |  France |
 |
Genfit SA
GNFT
|
626.29 | - | 2.54 % | $ 160 B | France |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-115.61 | - | -1.52 % | $ 24.7 M | USA |
 |
Athira Pharma
ATHA
|
-380.03 | - | - | $ 269 M | USA |
 |
Edesa Biotech
EDSA
|
-311.44 | $ 15.46 | - | $ 49.4 M | USA |
 |
Esperion Therapeutics
ESPR
|
7.51 | $ 3.11 | - | $ 646 M | USA |
 |
Exelixis
EXEL
|
36.21 | $ 44.42 | - | $ 12.1 B | USA |
 |
Fortress Biotech
FBIO
|
13.66 | $ 2.46 | - | $ 68.6 M | USA |
 |
Fennec Pharmaceuticals
FENC
|
-27.46 | $ 6.72 | - | $ 192 M | USA |
 |
Galectin Therapeutics
GALT
|
24.11 | $ 2.23 | - | $ 143 M | USA |
 |
Genprex
GNPX
|
-203.83 | $ 0.89 | - | $ 830 K | USA |
 |
Hutchison China MediTech Limited
HCM
|
36.91 | $ 13.3 | - | $ 11.4 B | China |
 |
Институт стволовых клеток человека
ISKJ
|
17.55 | - | - | - |  Russia |
 |
Checkmate Pharmaceuticals
CMPI
|
-88.4 | - | - | $ 231 M | USA |
 |
Immuron Limited
IMRN
|
-12.31 | $ 0.79 | - | $ 8.53 M |  Australia |
 |
INmune Bio
INMB
|
-195.26 | $ 1.54 | - | $ 38.1 M | USA |
 |
Ionis Pharmaceuticals
IONS
|
-46.9 | $ 75.25 | - | $ 12 B | USA |
 |
KalVista Pharmaceuticals
KALV
|
4039.99 | $ 26.71 | - | $ 1.44 B | Britain |
 |
ACADIA Pharmaceuticals
ACAD
|
30.9 | $ 22.35 | - | $ 3.7 B | USA |
 |
Kamada Ltd.
KMDA
|
9.59 | $ 8.21 | - | $ 260 M |  Israel |
 |
Kymera Therapeutics
KYMR
|
-19.71 | $ 82.71 | - | $ 6.99 B | USA |
 |
Galapagos NV
GLPG
|
-11.44 | $ 28.39 | - | $ 2.69 B |  Belgium |
 |
Grifols, S.A.
GRFS
|
9.2 | $ 8.27 | - | $ 6.83 B |  Spain |
 |
Advaxis
ADXS
|
196.88 | - | -9.65 % | $ 45.9 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-175.75 | $ 3.5 | - | $ 5.76 M | Israel |
 |
Aeterna Zentaris
AEZS
|
-401.79 | - | 5.93 % | $ 314 M |  Canada |
 |
Aeglea BioTherapeutics
AGLE
|
-21.7 | - | - | $ 1.01 B | USA |
 |
CureVac N.V.
CVAC
|
-59.8 | - | - | $ 867 M | Germany |
 |
Applied Genetic Technologies Corporation
AGTC
|
-62.37 | - | - | $ 26.5 M | USA |
 |
AIkido Pharma
AIKI
|
-32.34 | - | 1.93 % | $ 17.4 M | USA |
 |
Mirum Pharmaceuticals
MIRM
|
-7.42 | $ 105.81 | - | $ 5.31 B | USA |
 |
MannKind Corporation
MNKD
|
-11.49 | $ 2.86 | - | $ 874 M | USA |
 |
InflaRx N.V.
IFRX
|
-43.64 | $ 1.97 | - | $ 152 M | Germany |
 |
Akero Therapeutics
AKRO
|
-33.6 | - | - | $ 3.67 B | USA |
 |
Aptose Biosciences
APTO
|
93.75 | - | -45.71 % | $ 1.2 M | Canada |
 |
Aptinyx
APTX
|
-169.38 | - | -39.0 % | $ 4.57 M | USA |
 |
Akouos
AKUS
|
-37.09 | - | 0.23 % | $ 488 M | USA |
 |
Albireo Pharma
ALBO
|
-19.38 | - | -0.23 % | $ 916 M | USA |
 |
Allakos
ALLK
|
-110.0 | - | - | $ 28.6 M | USA |
 |
AlloVir
ALVR
|
-55.11 | - | 4.14 % | $ 49.1 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
-8.52 | $ 23.42 | - | $ 2.98 B | USA |
 |
Allena Pharmaceuticals
ALNA
|
-257.91 | - | 3.16 % | $ 1.9 M | USA |
 |
Nanobiotix S.A.
NBTX
|
-47.67 | $ 34.77 | - | $ 286 B | France |
 |
Ampio Pharmaceuticals
AMPE
|
-256.9 | - | -11.43 % | $ 502 K | USA |